Results 41 to 50 of about 1,075,882 (382)

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer

JAMA Network Open, 2020
Key Points Question Is the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to primary cytoreductive surgery (PCS) associated with better outcomes for patients with stage III epithelial ovarian cancer?
Z. Lei, Yue Wang, Jiahong Wang, Ke Wang, Jun Tian, Ying Zhao, Lipai Chen, Jin Wang, Jiali Luo, M. Jia, Hong-sheng Tang, Qingjun He, Quanxing Liao, Xiansheng Yang, T. Guan, Li Wang, S. Cui   +16 more
semanticscholar   +1 more source

Innovations and challenges in intraperitoneal chemotherapy for peritoneal metastatic carcinoma [PDF]

Zhongguo aizheng zazhi
Peritoneal metastatic carcinoma refers to the spread of malignant tumors from the primary site to the peritoneum. It is commonly observed in the advanced stages of various cancer types, including gastric cancer, colorectal cancer, ovarian cancer and ...
FENG Xinying, WANG Bing, LIU Peifeng
doaj   +1 more source

Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae

Pleura and Peritoneum, 2022
Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais, Liauw Winston, Kennedy Helen, Alzahrani Nayef A., Morris David L.   +4 more
doaj   +1 more source

Targeting the tumor microenvironment in colorectal peritoneal metastases

, 2020
Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC) patients. The pathophysiology of colorectal PM remains poorly characterized. Also, the efficacy of current treatment modalities, including surgery and intraperitoneal (
Ceelen, Wim, De Wever, Olivier, Heriot, Alexander G., Narasimhan, Vignesh, Ramsay, Robert G.   +4 more
core   +1 more source

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Journal of Clinical Oncology, 2019
PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. Here we aimed to
P. Bonnot, G. Piessen, V. Kepenekian, E. Decullier, M. Pocard, B. Meunier, J. Bereder, K. Abboud, F. Marchal, F. Quénet, D. Goéré, S. Msika, C. Arvieux, N. Pirró, R. Wernert, P. Rat, J. Gagnière, J. Lefèvre, T. Courvoisier, R. Kianmanesh, D. Vaudoyer, M. Rivoire, P. Meeus, G. Passot, O. Glehen   +24 more
semanticscholar   +1 more source

Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.

Current Oncology, 2020
Objective The purpose of the present review was to provide evidence-based guidance about the provision of cytoreductive surgery (crs) with hyperthermic intraperitoneal chemotherapy (hipec) in the treatment of peritoneal cancers.
R. Auer, D. Sivajohanathan, J. Biagi, J. Conner, E. Kennedy, T. May   +5 more
semanticscholar   +1 more source

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model

Pleura and Peritoneum, 2023
In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, administer intraperitoneal chemotherapy using the peritoneal infusion pump we developed in this model, and (2) compare the efficacy of intraperitoneal chemotherapy ...
Manoğlu Berke, Yavuzşen Tuğba, Aktaş Safiye, Altun Zekiye, Yılmaz Osman, Gökbayrak Özde Elif, Erol Aylin   +6 more
doaj   +1 more source

Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta‐analysis

Colorectal Disease, 2020
Peritoneal metastases from colorectal cancer confer the worst survival among all metastatic sites. The adoption of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can offer selected patients with isolated colorectal ...
V. Narasimhan, Sabrina Tan, Joseph C. H. Kong, T. Pham, M. Michael, R. Ramsay, S. Warrier, A. Heriot   +7 more
semanticscholar   +1 more source

Peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy

Journal of Coloproctology, 2018
Introduction: To evaluate the combined treatment with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from colorectal cancer, pseudomyxoma peritonei and mesothelioma.
Bernardo Hanan, Leonardo Maciel Fonseca, Magda Maria Profeta da Luz, Antônio Lacerda-Filho, Mônica Maria Demas Álvares Cabral, Rodrigo Gomes da Silva   +5 more
doaj   +1 more source

Impact of body mass index on surgical and oncological outcomes after Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

PLoS One
Ezanno AC, Poudevigne O, Quesada JL, Abba J, Malgras B, Trilling B, Sage PY, Fischer J, Pocard M, Arvieux C, Tidadini F.   +10 more
europepmc   +2 more sources